Highbridge Capital Management LLC Amgen Inc Call Options Transaction History

Highbridge Capital Management LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2018 Nov 13, 2018	SELL	$185.29 - $208.89 $426,167 - $480,446	-2,300 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$166.05 - $186.51 $166,050 - $186,510	1,000 Added 76.92%	2,300 $422,000
Q4 2017 Feb 14, 2018	SELL	$168.79 - $188.59 $506,370 - $565,770	-3,000 Reduced 69.77%	1,300 $227,000
Q3 2017 Nov 14, 2017	BUY	$167.29 - $191.0 $719,347 - $821,300	4,300	4,300 $805,000

3,122

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $149B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Highbridge Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Highbridge Capital Management LLC with notifications on news.